SEC Form 4 · accession 0001654954-19-002247
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan W Dunton
Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $1.70 | Mar 1, 2019 | A | 100,000 | A | — | Mar 1, 2029 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1These options were granted on 3/1/2019. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.